Commercial Credit Report for Farmatsiya OAO

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Farmatsiya OAO is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Farmatsiya OAO
Ulitsa Austrina, 145
Phone: +7 8412234545p:+7 8412234545	PENZA, 440015 Russian Federation	Ticker: frmcfrmc

On March 4, 2022, CreditRiskMonitor.com, Inc. suppressed the FRISK® score of all publicly listed Russian and Ukrainian-based companies trading domestically due to the closure of their respective stock markets. The halt of trading in a counterparty’s securities is never a positive signal for creditors or suppliers, but especially in situations where the prices of those securities were above book value before the halt. The loss of liquidity optionality from equity markets inherently increases the bankruptcy risks for any business and dealing with businesses who have lost this financing option should be strongly scrutinized. Stock Market data is one of the essential components used in the daily calculation of the FRISK®. The omission of this data can reduce the score's effectiveness in predicting bankruptcy risk for companies trading within these markets. In addition, any analysis based on previously reported financials should be used with caution in this environment. We are continuing to monitor the Russia-Ukraine conflict and plan to reevaluate the appropriateness of the FRISK® when the affected exchanges have reopened and trading in securities resumes.

Business Summary

Farmatsiya OAO (Pharmacia OJSC) is a Russia-based company primarily involved in the pharmaceuticals industry. The Company sales pharmaceutical products and medical goods on both: retail and wholesale market. Farmatsiya OAO distributes its products to its own drugstores, as well as to other drugstore chains and consumers from Ulyanovsk Oblast and Mordovia. The Company also offers paid medical services at its own medical and diagnostic center Eskulap. Farmatsiya OAO operates through a network of approximately 123 drugstores. The Company is active domestically, mainly on the Penza city and Penza Oblast. Farmatsiya OAO has 13 subsidiaries. As of September 30, 2014, the Company’s major shareholder was INTERMEDFARM OOO.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2022	12/31/2022	Yes	-	-	-	-

Industries

SIC Code	Description
5912	Drug stores and proprietary stores

Officers and Directors

Title	Name	Age	Title Date	Start Date
General Director	Lyubov I.Vasileva	58	5/6/2013	5/6/2013
Regional Manager, Human Resources Manager, Director	Svetlana I.Ageeva		5/6/2013	5/6/2013
Territorial Manager, Director	Natalia N.Zhemkova		5/6/2013	5/6/2013
3 additional Officers and Directors records available in full report.

Business Names

Business Name
FRMC
FRMCP

General Information

Number of Employees:	961	(As of 9/30/2011)
Outstanding Shares:	33,677	(As of 12/31/2022)
Shareholders:	83
Stock Exchange:	RTB
Fax Number:	+7 8412579784

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN